BIOS222 Pathology and Clinical Science 2

Size: px
Start display at page:

Download "BIOS222 Pathology and Clinical Science 2"

Transcription

1 BIOS222 Pathology and Clinical Science 2 Session 5 Lymphatic and Haematological Disorders 3 Bioscience Department

2 Session Learning Outcomes At the end of the session, you should be able to o Define and discuss the causes, clinical features, pathophysiology and management of Aplastic Anaemia. o Define and classify various types of haematological malignancies including various types of Leukaemia and Lymphomas. o Explain the pathophysiology, clinical features, classifications and management of different types of acute and chronic leukaemia. o Discuss Hodgkin s lymphoma and Non Hodgkin s lymphoma in terms of causes, clinical features, pathophysiology, and treatment. o Discuss the clinical features, investigations, and management of Paraproteinaemias - Multiple Myeloma. Endeavour College of Natural Health 2

3 Session Plan o Aplastic anaemia o Haematological malignancies Leukaemias Acute Lymphoblastic and Myeloid Leukaemia Chronic Lymphoblastic and Myeloid Leukaemia Lymphomas Hodgkin s Lymphoma Non Hodgkin's Lymphoma Paraproteinaemia Monoclonal gammopathy of uncertain significance (MGUS) Waldenstrom s macroglobulinaemia Multiple myeloma Endeavour College of Natural Health 3

4 Aplastic Anaemia Endeavour College of Natural Health 4

5 Aplastic Anaemia Definition: A disorder of pluripotential bone marrow stem cells that results in Pancytopenia. o Aetiology: Inherited defects (Rare) Fanconi s anaemia Dyskeratosis congenita Amegakaryocytic thrombocytopenia Acquired defects Primary idiopathic Secondary: Drugs Chemicals Radiation Viral hepatitis Pregnancy Paroxysmal nocturnal haemoglobinuria Endeavour College of Natural Health 5

6 o Pathophysiology: Aplastic Anaemia Inherited/ acquired defects stimulate cellular immune response production of cytokines (interferon, tumor necrosis factor [TNF]) by activated T cells cytokines suppress normal stem cell growth and development bone marrow aplasia Pancytopenia o Clinical features: Symptoms of bone marrow failure, usually anaemia or bleeding, and less commonly, infections. Endeavour College of Natural Health 6

7 Aplastic Anaemia o Diagnosis: Full blood count Peripheral blood smear Bone marrow examination o Management: Blood transfusion Bone marrow transplant Endeavour College of Natural Health 7

8 Aplastic Anaemia Aplastic bone marrow Normal bone marrow Endeavour College of Natural Health 8

9 Aplastic Anaemia: A pluripotential bone marrow stem cells disorder that results in bone marrow aplasia and Pancytopenia Inherited defects: Falconi s anaemia, Dyskaratosis congenital, Amegkaryocytic thrombocytopenia Cellular immune response cytokines (interferon, tumor necrosis factor [TNF]) production by activated T cells Normal stem cell growth and development suppressed Bone marrow aplasia Pancytopenia Symptoms of Anaemia: weakness, fatigability, and pallor, SOB, dizziness, heart murmur, cardiac enlargement, heart failure Symptoms of Thrombocytopenia: Patechia, easy bruising, bleeding from nose, gums,, stool Symptoms of neutropenia: predispositions to infections Acquired: idiopathic, Drugs, Chemicals, Radiation, Viral hepatitis, Pregnancy, Paroxysmal nocturnal haemoglobinuria Diagnosis: FBC Peripheral blood smear Bone marrow examination Management: Blood transfusion Bone marrow transplant Endeavour College of Natural Health 9

10 Leukaemias Endeavour College of Natural Health 10

11 Leukaemias Definition: Malignant disorders of the haematopoietic stem cell compartment, characteristically associated with increased numbers of white cells in the bone marrow and/or peripheral blood. o Risk factors: Ionising radiation Cytotoxic drugs Retroviruses Genetic Immunological Endeavour College of Natural Health 11

12 o Classification: Leukaemias Acute lymphoblastic leukaemia, ALL ( more common in children) Acute myeloid leukaemia, AML ( more common in elderly) Chronic lymphocytic leukaemia, CLL ( more common in elderly) Chronic myeloid leukaemia, CML ( more common in elderly) Endeavour College of Natural Health 12

13 Acute Leukaemias Definition: Sudden, rapidly progressive, uncontrolled proliferation of primitive stem cells, leading to an accumulation of blasts, predominantly in the bone marrow, leading to bone marrow failure and spilling of blast cells into the blood stream. o Classification: Acute lymphoblastic leukaemia (ALL) Involves lymphoid stem cells Four times more common in children Acute myeloid leukaemia (AML) Involves myeloid stem cells particularly granulomonocytes Four times more common in adults Endeavour College of Natural Health 13

14 o Pathophysiology: ALL Acute Leukaemias Chromosomal aberrations dysregulation of the expression and function of transcription factors required normal hematopoietic cell development altered hematopoiesis AML Acquired genetic alterations inhibit terminal myeloid differentiation accumulation of relatively undifferentiated blast cells in bone marrow suppression of the remaining progenitor cells that leads to anaemia, neutropenia, and thrombocytopenia Endeavour College of Natural Health 14

15 Acute Leukaemias o Clinical features: Fever, night sweat, weight loss, fatigue, pallor Bleeding in the gums, Petechial haemorrhage Enlargement of spleen and liver Infiltration of lymph nodes Tender bones and bone-pains esp. in children Sternum tender and painful Leukostasis leading to obstruction in the pulmonary and cerebral circulations. Cranial nerve palsies, headache, nausea, vomiting, papilledema, occasionally seizures and coma Sudden shortness of breath and progressive dyspnoea Endeavour College of Natural Health 15

16 o Diagnosis: Full blood count Peripheral blood smear Bone marrow examination Acute Leukaemias Immunophenotyping, chromosome and molecular analysis A. /hess-images/leukaemias/acute-myelogenous-leukaemia-m3-auer-rods- 100x.jpg/image_view_fullscreen B. Grossman, S, Porth, CM 2013, Porth s pathophysiology, Concepts of Altered Health States, 9th edn, Lippincott Williams & Wilkins A. Acute myeloblastic leukaemia: There are Auer rods in the cytoplasm of the blast cells in this smear. B. Acute lymphoblastic Leukaemia. There are irregular nuclei in the lymphoblasts in this blood smear. Endeavour College of Natural Health 16

17 o Management: Acute Leukaemias Specific therapy: to destroy the leukaemic clone of cells without destroying the residual normal stem cell compartment from which repopulation of the haematopoietic tissues will occur. Three phases: Remission induction: The bulk of the tumour is destroyed by combination chemotherapy Remission consolidation: If remission has been achieved, residual disease is attacked by therapy during this phase. Remission maintenance. A period of maintenance therapy is given, consisting of a repeating cycle of drug administration. This may extend for up to 3 years if relapse does not occur. Endeavour College of Natural Health 17

18 o Management: Acute Leukaemias Supportive therapy: To deal with periods of severe bone marrow failure. Red cell concentrate transfusions for Anaemia Platelet transfusions for Bleeding Parenteral broad-spectrum antibiotic therapy to prevent infection Prophylaxis for pneumonia, Oral and pharyngeal infection, systemic fungal infection, herpes simplex Treatments for metabolic problems treated accordingly if occurs Psychological support Endeavour College of Natural Health 18

19 Chronic Myeloid Leukaemias o Definition: a myeloproliferative stem cell disorder resulting in slow progressing proliferation of marrow granulocytes, erythroid precursors, and megakaryocytes. o Aetiology: Chromosome abnormality: Philadelphia(Ph) chromosome formed by reciprocal translocation t(9;22) Endeavour College of Natural Health 19

20 Chronic Myeloid Leukaemias o Pathophysiology: Translocation of genes from chromosome from 9 to 22 create a new BCR ABL fusion gene (an oncogene) on 22 a fusion protein, (tyrosine kinase) with increased phosphorylating activity altered cellular proliferation, differentiation and survival. o Clinical features: Three phases: A chronic phase of variable length A short accelerated phase A terminal blast crisis phase Endeavour College of Natural Health 20

21 Chronic Myeloid Leukaemias o Clinical features: (cont.) A chronic phase of variable length: Slow onset with chronic phase of 3-5 years duration Nonspecific symptoms such as weakness and weight loss Anaemia causing easy fatigability, and exertional dyspnoea Splenomegaly Hepatomegaly is less common Lymphadenopathy is relatively uncommon Endeavour College of Natural Health 21

22 Chronic Myeloid Leukaemias o Clinical features: (cont.) A short accelerated phase: Progressive symptoms with short phase of 6 to 12 months Constitutional symptoms such as low-grade fever, night sweats, bone pain, and weight loss Splenomegaly often causes a feeling of abdominal fullness and discomfort Bleeding and easy bruising may arise from dysfunctional platelets. Endeavour College of Natural Health 22

23 Chronic Myeloid Leukaemias o Clinical features: (cont.) A terminal blast crisis phase: Evolution to acute Leukaemia Constitutional symptoms become more pronounced Splenomegaly may increase significantly Leukemic cells infiltration into of skin, lymph nodes, bones, and CNS Symptoms of leukostasis with very high blast counts Endeavour College of Natural Health 23

24 Chronic Myeloid Leukaemias o Diagnosis: Full blood count Peripheral blood smear Bone marrow examination Karyotype RNA analysis of blood Serum LDH, urate and uric acid o Management: Chronic phase: Imatinib, dasatinib and nilotinib (tyrosine kinase inhibitor drugs) Accelerated phase and blast crisis: chemotherapy, allogeneic bone marrow transplant Endeavour College of Natural Health 24

25 Chronic Lymphocytic Leukaemias o Definition: It is a clonal malignancy of B lymphocytes characterized by uncontrolled proliferation and accumulation of mature immuno-incompetent B lymphocytes. o Clinical features: Often asymptomatic in the earlier stage Painless lymphadenopathy Hepatosplenomegaly Fever, abdominal pain, weight loss, Symptoms of progressive anaemia, thrombocytopenia and hypogammaglobinaemia Endeavour College of Natural Health 25

26 Chronic Lymphocytic Leukaemias Endeavour College of Natural Health 26

27 Chronic Lymphocytic Leukaemias o Diagnosis: Full blood count Peripheral blood smear Reticulocyte count and a direct Coombs test Immunophenotyping Serum immunoglobulin levels Bone marrow examination This peripheral blood smear shows an absolute lymphocytosis of small mature lymphocytes with clumped, smudgy chromatin and scant cytoplasm. Smudge cells (near the top right) are a common finding of Chronic lymphocytic Leukaemia Image from: ology-oncology/chronic-leukaemias/ Endeavour College of Natural Health 27

28 Chronic Lymphocytic Leukaemias o Management: Stage A: No specific treatment Stages B and C: Oral chemotherapy with chlorambucil. Corticosteroids Blood transfusion Radiotherapy Splenectomy Stem cell transplant o Complications: Autoimmune haemolytic anaemia Thrombocytopenia High grade non- Hodgkin s lymphoma (Richter s transformation) Hairy cell Leukaemia Endeavour College of Natural Health 28

29 Lymphomas Endeavour College of Natural Health 29

30 Lymphomas o Definition: A diverse group of solid tumours composed of neoplastic lymphoid cells that vary with respect to molecular features, genetics, clinical presentation, and treatment. o Classification: Hodgkin s lymphoma Non Hodgkin s lymphoma Endeavour College of Natural Health 30

31 Hodgkin s Lymphomas o Definition: A specialized form of lymphoma that features the presence of an abnormal cell called a Reed- Sternberg cell. o Aetiology: Unknown More common in patients from well-educated backgrounds and small families Three times more likely with a past history of infectious mononucleosis but no definitive causal link to Epstein Barr virus infection is proven Endeavour College of Natural Health 31

32 o Clinical features: Hodgkin s Lymphomas Fever, chills, night sweats and weight loss Pruritus and intermittent fevers associated with night sweats Painless enlargement of lymph nodes (mainly above diaphragm) Mediastinal masses Chest discomfort with cough or dyspnoea Fatigue and anaemia Predisposition to infections Endeavour College of Natural Health 32

33 Hodgkin s Lymphomas o Diagnosis: Lymph node biopsy Full blood count Liver function test Serum LDH level Chest X-ray CT scan of chest, abdomen and pelvis Classic Reed-Sternberg cell with two nuclei containing a prominent eosinophilic nucleolus Grossman, S, Porth, CM 2013, Porth s pathophysiology, Concepts of Altered Health States, 9th edn, Lippincott Williams & Wilkins Endeavour College of Natural Health 33

34 o Management: Hodgkin s Lymphomas Early stage disease: Chemotherapy and adjunctive radiotherapy Advanced-stage disease: Chemotherapy alone Disease resistant to therapy: Autologous Hematopoietic stem cell transplantation(hsct) o Complications: Mainly due to treatment Cardiac and pulmonary toxicity, Breast cancer, lung cancer Secondary myelodysplasia/aml Endeavour College of Natural Health 34

35 Non-Hodgkin's Lymphomas o Definition: It represents a monoclonal proliferation of lymphoid cells of B cell (70%) or T cell (30%) origin. o Classification: Nodular lymphoma Diffused lymphoma Low grade lymphoma High grade lymphoma T cells lymphoma B cell lymphoma o Aetiology: Viral infections Helicobacter pylori Chromosomal translocations Congenital immunodeficiency Immunosuppressed patients Endeavour College of Natural Health 35

36 Non-Hodgkin's Lymphomas o Clinical features: Peripheral lymphadenopathy mainly mediastinal, intra-abdominal and pelvic Involvement of extra-nodal sites like bone marrow, gut, thyroid, lung, skin, testis, brain and, more rarely, bone Weight loss, sweats, fever and itching Hepatosplenomegaly Gut obstruction, ascites, superior vena cava obstruction and spinal cord compression Endeavour College of Natural Health 36

37 Non-Hodgkin's Lymphomas o Diagnosis: Same investigations as Hodgkin s lymphoma Other tests: Immunophenotyping Cytogenetic analysis Immunoglobulin determination Serum uric acid HIV testing Low-grade follicular or nodular NHL Images from: Walker, BR, Colledge, NR, Ralston, SH, & Penman, ID (eds) 2014, Davidson s principles and practice of medicine, 22nd edn, Churchill Livingstone Elsevier, Edinburgh. (High-grade) diffuse NHL Endeavour College of Natural Health 37

38 Non-Hodgkin s Lymphomas o Management: Asymptomatic patients may not require therapy. Indications for treatment: Marked systemic symptoms, lymphadenopathy causing discomfort or disfigurement, bone marrow failure or compression syndromes Treatment options: Radiotherapy Chemotherapy HSCT Endeavour College of Natural Health 38

39 Paraproteinaemia Endeavour College of Natural Health 39

40 Paraproteinaemias o Definition: Overproduction of one or more classes of immunoglobulin. May be monoclonal or polyclonal. o Conditions: Monoclonal gammopathy of uncertain significance Waldenstrom macroglobulinaemia Multiple myeloma Endeavour College of Natural Health 40

41 Monoclonal gammopathy of uncertain significance o Definition: A condition with the presence of the monoclonal immunoglobulin in the serum without other findings of multiple myeloma, Waldenstrom macroglobulinaemia, lymphoma or related disease. o Clinical features: Asymptomatic o Diagnosis: Routine blood count and biochemistry are normal Monoclonal paraprotein is usually present in small amounts with no lytic bone lesions. The bone marrow may have increased plasma cells Endeavour College of Natural Health 41

42 Waldernstrom Macroglobulinaemia o Definition: This is a low-grade lymphoplasmacytoid lymphoma associated with an IgM paraprotein, causing clinical features of hyperviscosity syndrome. o Clinical features: Nosebleeds, bruising, confusion and visual disturbance Anaemia Systemic symptoms Splenomegaly or lymphadenopathy. Endeavour College of Natural Health 42

43 Waldernstrom Macroglobulinaemia o Diagnosis: IgM paraprotein associated with a raised plasma viscosity The bone marrow with infiltration of lymphoid cells and prominent mast cells o Management: Plasmapheresis to remove IgM Blood transfusion Chemotherapy with alkylating agents, such as chlorambucil Endeavour College of Natural Health 43

44 Multiple Myeloma o Definition: This is a malignant proliferation of plasma cells that produce immunoglobulin of a single heavy and light chain, a monoclonal protein commonly referred to as a paraprotein. In some cases, only light chain is produced. Walker, BR, Colledge, NR, Ralston, SH, & Penman, ID (eds) 2014, Davidson s principles and practice of medicine, 22nd edn, Churchill Livingstone Elsevier, Edinburgh. Endeavour College of Natural Health 44

45 o Clinical features: The main sites involved are: Bones Bone marrow Multiple Myeloma Signs and symptoms are shown in the image Grossman, S, Porth, CM 2013, Porth s pathophysiology, Concepts of Altered Health States, 9th edn, Lippincott Williams & Wilkins Endeavour College of Natural Health 45

46 o Diagnosis: Multiple Myeloma Based on two of the following criteria: Increased malignant plasma cells in the bone marrow Serum and/or urinary M-protein Skeletal lytic lesions o Management: Immediate support Chemotherapy with or without HSCT Radiotherapy Bisphosphonates Endeavour College of Natural Health 46

47 Reading and Resources o o o o o o o Crowley LV, 2012, An Introduction to Human Diseases Pathology and Pathophysiology Correlations, 9th edn, Jones and Bartlett Learning Grossman SC & Porth CM 2014, Porth s Pathophysiology- Concepts of Altered Health States, 9th edn. Wolters Kluwer Health - Lippincott, Williams & Wilkins Hinson, J, Raven, P & Chew, S 2010, The endocrine system: basic science and clinical conditions, 2nd edn, Churchill Livingstone Elsevier, Edinburgh Jamison, JR 2006, Differential diagnosis for primary care: a handbook for health care practitioners, 2nd edn, Churchill Livingstone Elsevier, Edinburgh. Jarvis, C, 2012 Physical Examination & Health Assessment, 6th ed., Elsevier Saunders, Philadelphia. Kumar, P & Clark, M 2012, Kumar and Clark s clinical medicine, 8th edn, Saunders Elsevier, Edinburgh. Kumar, V, Abbas, AK & Aster, JC 2015, Robbins & Cotran pathologic basis of disease, 9th edn, Elsevier Saunders, Philadelphia. Endeavour College of Natural Health 47

48 o o o o o o Reading and Resources Lee, G & Bishop, P 2009, Microbiology and infection control for health professionals, 4th edn, Pearson Education, Frenchs Forest, NSW. McCance, KL, Heuther, SE, & Brashers, VL 2014, Pathophysiology: the biologic basis for disease in adults and children, 7th edn, Elsevier. Michael-Titus, A, Revest, P & Shortland, P 2010, The nervous system: basic science and clinical conditions, 2nd edn, Churchill Livingstone Elsevier, Edinburgh Mosby s dictionary of medicine, nursing and health professions 2013, 9th edn, Elsevier, St. Louis, MO. Tortora, GJ & Derrickson, B 2014, Principles of anatomy and physiology, 14th edn, John Wiley & Sons, Hoboken, NJ. VanMeter, KC & Hubert, RJ 2014, Gould's pathophysiology for the health professions, 5th edn, Elsevier, St Louis, MO. o Walker, BR, Colledge, NR, Ralston, SH, & Penman, ID (eds) 2014, Davidson s principles and practice of medicine, 22nd edn, Churchill Livingstone Elsevier, Edinburgh. Endeavour College of Natural Health 48

49 COMMONWEALTH OF AUSTRALIA Copyright Regulations 1969 WARNING This material has been reproduced and communicated to you by or on behalf of the Endeavour College of Natural Health pursuant to Part VB of the Copyright Act 1968 (the Act). The material in this communication may be subject to copyright under the Act. Any further reproduction or communication of this material by you may be the subject of copyright protection under the Act. Do not remove this notice. Endeavour College of Natural Health 49

BIOS222 Pathology and Clinical Science 2

BIOS222 Pathology and Clinical Science 2 BIOS222 Pathology and Clinical Science 2 Session 3 Lymphatic and Haematological Disorders 1 Bioscience Department www.endeavour.edu.au Session Learning Outcomes At the end of this session, you should be

More information

Leukemias. Prof. Mutti Ullah Khan Head of Department Medical Unit-II Holy Family Hospital Rawalpindi Medical College

Leukemias. Prof. Mutti Ullah Khan Head of Department Medical Unit-II Holy Family Hospital Rawalpindi Medical College Leukemias Prof. Mutti Ullah Khan Head of Department Medical Unit-II Holy Family Hospital Rawalpindi Medical College Introduction Leukaemias are malignant disorders of the haematopoietic stem cell compartment,

More information

WBCs Disorders 1. Dr. Nabila Hamdi MD, PhD

WBCs Disorders 1. Dr. Nabila Hamdi MD, PhD WBCs Disorders 1 Dr. Nabila Hamdi MD, PhD ILOs Compare and contrast ALL, AML, CLL, CML in terms of age distribution, cytogenetics, morphology, immunophenotyping, laboratory diagnosis clinical features

More information

BIOS222 Pathology and Clinical Science 2 & 3

BIOS222 Pathology and Clinical Science 2 & 3 BIOS222 Pathology and Clinical Science 2 & 3 Session 16 Endocrine system disorders 3 Bioscience Department www.endeavour.edu.au Session Learning Outcomes At the end of the session, you should be able to:

More information

HAEMATOLOGICAL MALIGNANCY

HAEMATOLOGICAL MALIGNANCY HAEMATOLOGICAL MALIGNANCY Reference Compulsory reading Haematology at Glance 2 nd ed. Atul Mehta & Victor Hoffbrand Chapters: 20 to 31 Pages: 46 to 69 Pathogenesis of Haematological Malignancy Figure (a)

More information

LEUKAEMIA and LYMPHOMA. Dr Mubarak Abdelrahman Assistant Professor Jazan University

LEUKAEMIA and LYMPHOMA. Dr Mubarak Abdelrahman Assistant Professor Jazan University LEUKAEMIA and LYMPHOMA Dr Mubarak Abdelrahman Assistant Professor Jazan University OBJECTIVES Identify etiology and epidemiology for leukemia and lymphoma. Discuss common types of leukemia. Distinguish

More information

Neoplastic proliferation arising from white blood cells. Introductory remarks. Classification

Neoplastic proliferation arising from white blood cells. Introductory remarks. Classification Neoplastic proliferation arising from white blood cells Lymphoproliferative and myeloproliferative diseases and syndromes Oliver Rácz, 2012-2017 1 Introductory remarks Leukemia and lymphoma are old descriptive

More information

Pathology of Hematopoietic and Lymphoid tissue

Pathology of Hematopoietic and Lymphoid tissue CONTENTS Pathology of Hematopoietic and Lymphoid tissue White blood cells and lymph nodes Quantitative disorder of white blood cells Reactive lymphadenopathies Infectious lymphadenitis Tumor metastasis

More information

BIOS222 Pathology and Clinical Science 2 & 3

BIOS222 Pathology and Clinical Science 2 & 3 BIOS222 Pathology and Clinical Science 2 & 3 Session 10 Disorders of Musculoskeletal System 1 Bioscience Department www.endeavour.edu.au Session Learning Outcomes At the end of the session, you should

More information

Pathology of Hematopoietic and Lymphoid tissue

Pathology of Hematopoietic and Lymphoid tissue Pathology of Hematopoietic and Lymphoid tissue Peerayut Sitthichaiyakul, M.D. Department of Pathology and Forensic Medicine Faculty of Medicine, Naresuan University CONTENTS White blood cells and lymph

More information

Group of malignant disorders of the hematopoietic tissues characteristically associated with increased numbers of white cells in the bone marrow and

Group of malignant disorders of the hematopoietic tissues characteristically associated with increased numbers of white cells in the bone marrow and Group of malignant disorders of the hematopoietic tissues characteristically associated with increased numbers of white cells in the bone marrow and / or peripheral blood Classified based on cell type

More information

Non-Hodgkin lymphomas (NHLs) Hodgkin lymphoma )HL)

Non-Hodgkin lymphomas (NHLs) Hodgkin lymphoma )HL) Non-Hodgkin lymphomas (NHLs) Hodgkin lymphoma )HL) Lymphoid Neoplasms: 1- non-hodgkin lymphomas (NHLs) 2- Hodgkin lymphoma 3- plasma cell neoplasms Non-Hodgkin lymphomas (NHLs) Acute Lymphoblastic Leukemia/Lymphoma

More information

Pathology. #11 Acute Leukemias. Farah Banyhany. Dr. Sohaib Al- Khatib 23/2/16

Pathology. #11 Acute Leukemias. Farah Banyhany. Dr. Sohaib Al- Khatib 23/2/16 35 Pathology #11 Acute Leukemias Farah Banyhany Dr. Sohaib Al- Khatib 23/2/16 1 Salam First of all, this tafreegh is NOT as long as you may think. If you just focus while studying this, everything will

More information

Lymphoma: What You Need to Know. Richard van der Jagt MD, FRCPC

Lymphoma: What You Need to Know. Richard van der Jagt MD, FRCPC Lymphoma: What You Need to Know Richard van der Jagt MD, FRCPC Overview Concepts, classification, biology Epidemiology Clinical presentation Diagnosis Staging Three important types of lymphoma Conceptualizing

More information

Lec-14 د.خالد نافع. Medicine. Multiple Myeloma

Lec-14 د.خالد نافع. Medicine. Multiple Myeloma Fifth stage Lec-14 د.خالد نافع Medicine 24/4/2016 Multiple Myeloma Plasma cell myeloma Variants Non - secretory myeloma Indolent myeloma Smouldering myeloma Plasma cell leukaemia Plasmacytoma - Solitary

More information

What is a hematological malignancy? Hematology and Hematologic Malignancies. Etiology of hematological malignancies. Leukemias

What is a hematological malignancy? Hematology and Hematologic Malignancies. Etiology of hematological malignancies. Leukemias Hematology and Hematologic Malignancies Cancer of the formed elements of the blood What is a hematological malignancy? A hematologic malignancy is a malignancy (or cancer) of any of the formed elements

More information

If unqualified, Complete remission is considered to be Haematological complete remission

If unqualified, Complete remission is considered to be Haematological complete remission Scroll right to see the database codes for Disease status and Response Diagnosis it refers to Disease status or response to treatment AML ALL CML CLL MDS or MD/MPN or acute leukaemia secondary to previous

More information

Acute Lymphoblastic Leukaemia

Acute Lymphoblastic Leukaemia Acute Lymphoblastic Leukaemia Terri Boyer 17 th October 2006 Overview Disease information: Aetiology of ALL proposed theory, contributing factors Symptoms Complications Diagnostic approaches - morphology

More information

If unqualified, Complete remission is considered to be Haematological complete remission

If unqualified, Complete remission is considered to be Haematological complete remission Scroll right to see the database codes for Disease status and Response Diagnosis it refers to Disease status or response to treatment AML ALL CML CLL MDS or MD/MPN or acute leukaemia secondary to previous

More information

BIOS222 Pathology and Clinical Science 2 & 3

BIOS222 Pathology and Clinical Science 2 & 3 BIOS222 Pathology and Clinical Science 2 & 3 Session 12 Disorders of Musculoskeletal System 3 Bioscience Department www.endeavour.edu.au Session Learning Outcomes At the end of the session, student should

More information

BIOS222 Pathology and Clinical Science 2

BIOS222 Pathology and Clinical Science 2 BIOS222 Pathology and Clinical Science 2 Session 4 Lymphatic and Haematological Disorders 2 Bioscience Department www.endeavour.edu.au Session Learning Outcomes At the end of the session, you should be

More information

WBCs Disorders. Dr. Nabila Hamdi MD, PhD

WBCs Disorders. Dr. Nabila Hamdi MD, PhD WBCs Disorders Dr. Nabila Hamdi MD, PhD ILOs Compare and contrast ALL, AML, CLL, CML in terms of age distribution, cytogenetics, morphology, immunophenotyping, laboratory diagnosis clinical features and

More information

Neoplasia 2. Lecture 9. Pathology and Clinical Science 1 (BIOC211) Department of Bioscience. endeavour.edu.au

Neoplasia 2. Lecture 9. Pathology and Clinical Science 1 (BIOC211) Department of Bioscience. endeavour.edu.au Neoplasia 2 Lecture 9 Pathology and Clinical Science 1 (BIOC211) Department of Bioscience Text Reference: Grossman, S.C. & Porth, C.M. (2014). Porth s Pathophysiology: concepts of altered health states,

More information

Pediatric Oncology. Vlad Radulescu, MD

Pediatric Oncology. Vlad Radulescu, MD Pediatric Oncology Vlad Radulescu, MD Objectives Review the epidemiology of childhood cancer Discuss the presenting signs and symptoms, general treatment principles and overall prognosis of the most common

More information

BIOS222 Pathology and Clinical Science 2 & 3

BIOS222 Pathology and Clinical Science 2 & 3 BIOS222 Pathology and Clinical Science 2 & 3 Session 6 Lymphatic and Haematological Disorders 4 Bioscience Department www.endeavour.edu.au Session Learning Outcomes At the end of the session, student should

More information

Myelodysplastic syndrome (MDS) & Myeloproliferative neoplasms

Myelodysplastic syndrome (MDS) & Myeloproliferative neoplasms Myelodysplastic syndrome (MDS) & Myeloproliferative neoplasms Myelodysplastic syndrome (MDS) A multipotent stem cell that can differentiate into any of the myeloid lineage cells (RBCs, granulocytes, megakaryocytes)

More information

CHAPTER:4 LEUKEMIA. BY Mrs. K.SHAILAJA., M. PHARM., LECTURER DEPT OF PHARMACY PRACTICE, SRM COLLEGE OF PHARMACY 8/12/2009

CHAPTER:4 LEUKEMIA. BY Mrs. K.SHAILAJA., M. PHARM., LECTURER DEPT OF PHARMACY PRACTICE, SRM COLLEGE OF PHARMACY 8/12/2009 LEUKEMIA CHAPTER:4 1 BY Mrs. K.SHAILAJA., M. PHARM., LECTURER DEPT OF PHARMACY PRACTICE, SRM COLLEGE OF PHARMACY Leukemia A group of malignant disorders affecting the blood and blood-forming tissues of

More information

Easy Trick to Spot Leukemia for Pediatricians

Easy Trick to Spot Leukemia for Pediatricians Easy Trick to Spot Leukemia for Pediatricians Piya Rujkijyanont, MD Division of Hematology-Oncology Department of Pediatrics Phramongkutklao Hospital Most Common Pediatric Cancers Age 0-14 Leukemia 32%

More information

Myeloproliferative Disorders - D Savage - 9 Jan 2002

Myeloproliferative Disorders - D Savage - 9 Jan 2002 Disease Usual phenotype acute leukemia precursor chronic leukemia low grade lymphoma myeloma differentiated Total WBC > 60 leukemoid reaction acute leukemia Blast Pro Myel Meta Band Seg Lymph 0 0 0 2

More information

MYELOPROLIFARATIVE NEOPLASMS. Dr. Hasan Fahmawi, MRCP(UK), FRCP(Edin).

MYELOPROLIFARATIVE NEOPLASMS. Dr. Hasan Fahmawi, MRCP(UK), FRCP(Edin). MYELOPROLIFARATIVE NEOPLASMS Dr. Hasan Fahmawi, MRCP(UK), FRCP(Edin). These are a group of chronic conditions characterised by clonal proliferation of marrow precursor cells. PRV, essential thrombocyathaemia,

More information

Charles Mxxx DCEM2 Toulouse Purpan Medical School 01/26/2012 ECN Item 162

Charles Mxxx DCEM2 Toulouse Purpan Medical School 01/26/2012 ECN Item 162 Charles Mxxx DCEM2 Toulouse Purpan Medical School 01/26/2012 ECN Item 162 Definition Pathophysiology Clinical signs and symptoms Biology and Diagnosis Different types of AL Prognosis and Treatment Malignant

More information

Acute myeloid leukemia. M. Kaźmierczak 2016

Acute myeloid leukemia. M. Kaźmierczak 2016 Acute myeloid leukemia M. Kaźmierczak 2016 Acute myeloid leukemia Malignant clonal disorder of immature hematopoietic cells characterized by clonal proliferation of abnormal blast cells and impaired production

More information

Myeloid neoplasms. Early arrest in the blast cell or immature cell "we call it acute leukemia" Myoid neoplasm divided in to 3 major categories:

Myeloid neoplasms. Early arrest in the blast cell or immature cell we call it acute leukemia Myoid neoplasm divided in to 3 major categories: Myeloid neoplasms Note: Early arrest in the blast cell or immature cell "we call it acute leukemia" Myoid neoplasm divided in to 3 major categories: 1. AML : Acute myeloid leukemia(stem cell with myeloid

More information

Year 2002 Paper two: Questions supplied by Jo 1

Year 2002 Paper two: Questions supplied by Jo 1 Year 2002 Paper two: Questions supplied by Jo 1 Question 70 A 25 year old previously well male student presents with recent exertional dyspnoea, epistaxis and bruising. There is no history of medication,

More information

WHAT ARE PAEDIATRIC CANCERS

WHAT ARE PAEDIATRIC CANCERS WHAT ARE PAEDIATRIC CANCERS INTRODUCTION Childhood cancers are RARE 0.5% of all cancers in the West Overall risk that a child will develop cancer during first 15 years of life is 1 in 450 and 1 in 600

More information

Done By : WESSEN ADNAN BUTHAINAH AL-MASAEED

Done By : WESSEN ADNAN BUTHAINAH AL-MASAEED Done By : WESSEN ADNAN BUTHAINAH AL-MASAEED Acute Myeloid Leukemia Firstly we ll start with this introduction then enter the title of the lecture, so be ready and let s begin by the name of Allah : We

More information

PROBLEMS OF THE HEMATOLOGICAL SYSTEM

PROBLEMS OF THE HEMATOLOGICAL SYSTEM PROBLEMS OF THE HEMATOLOGICAL SYSTEM UNIT 5 Review A & P of Hematological system Outline focused exam Differentiate and start to evaluate diagnostic exams used to assess problems of the hematological system

More information

Contents SECTION 1: PHYSIOLOGY OF BLOOD

Contents SECTION 1: PHYSIOLOGY OF BLOOD Contents SECTION 1: PHYSIOLOGY OF BLOOD Chapter 1: Overview of Physiology of Blood 1 Normal Haematopoiesis 1 Red Blood Cells 6 White Blood Cells 15 Immune System 27 Megakaryopoiesis 32 Normal Haemostasis

More information

7 Omar Abu Reesh. Dr. Ahmad Mansour Dr. Ahmad Mansour

7 Omar Abu Reesh. Dr. Ahmad Mansour Dr. Ahmad Mansour 7 Omar Abu Reesh Dr. Ahmad Mansour Dr. Ahmad Mansour -Leukemia: neoplastic leukocytes circulating in the peripheral bloodstream. -Lymphoma: a neoplastic process in the lymph nodes, spleen or other lymphatic

More information

Lymphatic System Disorders

Lymphatic System Disorders Lymphatic System Disorders Lymphomas Malignant neoplasms involving lymphocyte proliferation in lymph nodes Specific causes not identified // Higher risk in adults who received radiation during childhood

More information

MS.4/ Acute Leukemia: AML. Abdallah Al Abbadi.MD.FRCP.FRCPath Feras Fararjeh MD

MS.4/ Acute Leukemia: AML. Abdallah Al Abbadi.MD.FRCP.FRCPath Feras Fararjeh MD MS.4/ 27.02.2019 Acute Leukemia: AML Abdallah Al Abbadi.MD.FRCP.FRCPath Feras Fararjeh MD Case 9: Acute Leukemia 29 yr old lady complains of fever and painful gums for 1 week. She developed easy bruising

More information

Instructions for Chronic Lymphocytic Leukemia Post-HSCT Data (Form 2113)

Instructions for Chronic Lymphocytic Leukemia Post-HSCT Data (Form 2113) Instructions for Chronic Lymphocytic Leukemia Post-HSCT Data (Form 2113) This section of the CIBMTR Forms Instruction Manual is intended to be a resource for completing the CLL Post-HSCT Data Form. E-mail

More information

Non-Hodgkin lymphoma

Non-Hodgkin lymphoma Non-Hodgkin lymphoma Non-Hodgkin s lymphoma Definition: - clonal tumours of mature and immature B cells, T cells or NK cells - highly heterogeneous, both histologically and clinically Non-Hodgkin lymphoma

More information

Heme 9 Myeloid neoplasms

Heme 9 Myeloid neoplasms Heme 9 Myeloid neoplasms The minimum number of blasts to diagnose acute myeloid leukemia is 5% 10% 20% 50% 80% AML with the best prognosis is AML with recurrent cytogenetic abnormality AML with myelodysplasia

More information

Blood Cancer: Chronic Myelogenous Leukaemia

Blood Cancer: Chronic Myelogenous Leukaemia Published on: 30 May 2017 Blood Cancer: Chronic Myelogenous Leukaemia What Is Cancer? The body is made up of cells that grow and die in a controlled way. Sometimes, cells keep dividing and growing without

More information

Hematology 101. Rachid Baz, M.D. 5/16/2014

Hematology 101. Rachid Baz, M.D. 5/16/2014 Hematology 101 Rachid Baz, M.D. 5/16/2014 Florida 101 Epidemiology Estimated prevalence 8,000 individuals in U.S (compare with 80,000 MM patients) Annual age adjusted incidence 3-8/million-year 1 More

More information

r). SUPPLEMENTARY/SECOND OPPORTUNITY EXAMINATION PAPER nnmlbih UNIVERSITY Sophia Blaauw INSTRUCTIONS FACULTY OF HEALTH AND APPLIED SCIENCES

r). SUPPLEMENTARY/SECOND OPPORTUNITY EXAMINATION PAPER nnmlbih UNIVERSITY Sophia Blaauw INSTRUCTIONS FACULTY OF HEALTH AND APPLIED SCIENCES r). nnmlbih UNIVERSITY OF SCIEFICE nnd TECHNOLOGY FACULTY OF HEALTH AND APPLIED SCIENCES DEPARTMENT OF HEALTH SCIENCES QUALIFICATION: BACHELOR OF MEDICAL LABORATORY SCIENCES QUALIFICATION CODE: 08BMLS

More information

Large cell immunoblastic Diffuse histiocytic (DHL) Lymphoblastic lymphoma Diffuse lymphoblastic Small non cleaved cell Burkitt s Non- Burkitt s

Large cell immunoblastic Diffuse histiocytic (DHL) Lymphoblastic lymphoma Diffuse lymphoblastic Small non cleaved cell Burkitt s Non- Burkitt s Non Hodgkin s Lymphoma Introduction 6th most common cause of cancer death in United States. Increasing in incidence and mortality. Since 1970, the incidence of has almost doubled. Overview The types of

More information

Classification of Hematologic Malignancies. Patricia Aoun MD MPH

Classification of Hematologic Malignancies. Patricia Aoun MD MPH Classification of Hematologic Malignancies Patricia Aoun MD MPH Objectives Know the basic principles of the current classification system for hematopoietic and lymphoid malignancies Understand the differences

More information

Clinical & Laboratory Assessment

Clinical & Laboratory Assessment Clinical & Laboratory Assessment Dr Roger Pool NHLS & University of Pretoria Clinical Assessment (History) Anaemia ( haemoglobin) Dyspnoea (shortness of breath) Tiredness Angina Headache Clinical Assessment

More information

Leukemia and Myelodysplastic Syndromes

Leukemia and Myelodysplastic Syndromes Leukemia and Myelodysplastic Syndromes Lenise Taylor, RN, MN, AOCNS Heme Malignancies/BMT CNS Seattle Cancer Care Alliance/UWMC Lymphoid 1 Myeloid 2 Presenting Signs and Symptoms Diagnostic Evaluation

More information

MECHANISMS OF HUMAN DISEASE: LABORATORY SESSIONS LYMPHOMA. April 16, 2008

MECHANISMS OF HUMAN DISEASE: LABORATORY SESSIONS LYMPHOMA. April 16, 2008 MECHANISMS OF HUMAN DISEASE: LABORATORY SESSIONS LYMPHOMA April 16, 2008 FACULTY COPY GOAL: Learn the appearance of normal peripheral blood elements and lymph nodes. Recognize abnormal peripheral blood

More information

Blood Cancers in the Community

Blood Cancers in the Community Over to you, mate Blood Cancers in the Community National Rural Health Conference NZ Rural General Practice Network April 7, 2018 Brian Grainger Haematology Registrar Auckland Acknowledgements Dr James

More information

Lymphomas and multiple myeloma 12/23/2018 1

Lymphomas and multiple myeloma 12/23/2018 1 60 Lymphomas and multiple myeloma 12/23/2018 1 Lymphomas Lymphoma is cancer of the lymphatic system. Lymphomas are subdivided into two main categories: Hodgkin's lymphoma (HL) and non- Hodgkin's lymphoma

More information

12 Dynamic Interactions between Hematopoietic Stem and Progenitor Cells and the Bone Marrow: Current Biology of Stem Cell Homing and Mobilization

12 Dynamic Interactions between Hematopoietic Stem and Progenitor Cells and the Bone Marrow: Current Biology of Stem Cell Homing and Mobilization Table of Contents: PART I: Molecular and Cellular Basis of Hematology 1 Anatomy and Pathophysiology of the Gene 2 Genomic Approaches to Hematology 3 Regulation of Gene Expression, Transcription, Splicing,

More information

Hodgkin's Lymphoma. Symptoms. Types

Hodgkin's Lymphoma. Symptoms. Types Hodgkin's lymphoma (Hodgkin's disease) usually develops in the lymphatic system, a part of the body's immune system. This system carries disease-fighting white blood cells throughout the body. Lymph tissue

More information

Myelodysplasia/Myeloproliferative Neoplasms (MDS/MPN) Post-HCT Data

Myelodysplasia/Myeloproliferative Neoplasms (MDS/MPN) Post-HCT Data Instructions for Myelodysplasia/Myeloproliferative Neoplasms (MDS/MPN) Post-HCT Data (Form 2114) This section of the CIBMTR Forms Instruction Manual is intended to be a resource for completing the Myelodysplasia/Myeloproliferative

More information

FBC CASES Vernon Louw Clinical Haematology 2010

FBC CASES Vernon Louw Clinical Haematology 2010 FBC CASES Vernon Louw Clinical Haematology 2010 FOR EACH OF THE FOLLOWING PATIENTS, SELECT THE MOST LIKELY FINDING FROM THE ANALYSIS OF THE PERIPHERAL BLOOD. A patient with infectious mononucleosis. A

More information

Bone marrow aspiration as the initial diagnostic tool in the diagnosis of leukemia - A case study

Bone marrow aspiration as the initial diagnostic tool in the diagnosis of leukemia - A case study Original Research Article Bone marrow aspiration as the initial diagnostic tool in the diagnosis of leukemia - A case study Priyanka Poonam 1*, N.K. Bariar 2 1 Tutor, Department of Pathology, Patna Medical

More information

1 Introduction. 1.1 Cancer. Introduction

1 Introduction. 1.1 Cancer. Introduction Introduction 1 1.1 Cancer 1 Introduction Cancer is the most precarious disease characterized by uncontrolled proliferation of cells without any physiological demands of the organism. Cancer may be defined

More information

Disclosures/COI. Cases in Hematopathology. Outline. Heme Path Findings Not to Miss. Normal Peripheral Smear 6/30/2016

Disclosures/COI. Cases in Hematopathology. Outline. Heme Path Findings Not to Miss. Normal Peripheral Smear 6/30/2016 Disclosures/COI Cases in Hematopathology Vamsi Kota Assistant Professor Department of Hematology & Medical Oncology Leukemia/BMT I have no disclosures or conflicts of interest regarding this presentation.

More information

Haematological Cancer Suspected (Adults & Children)

Haematological Cancer Suspected (Adults & Children) Haematological Cancer Suspected (Adults & Children) Link to NICE guidelines: https://www.nice.org.uk/guidance/ng47 Patient of any age presents with symptoms of possible haematological cancer If 60 years

More information

Leukemia. There are different types of leukemia and several treatment options for each type.

Leukemia. There are different types of leukemia and several treatment options for each type. Leukemia Introduction Leukemia is the name of a group of cancers of the blood cells. Hundreds of thousands of people worldwide are diagnosed with leukemia each year. There are different types of leukemia

More information

BIOS222 Pathology and Clinical Science 2 & 3

BIOS222 Pathology and Clinical Science 2 & 3 BIOS222 Pathology and Clinical Science 2 & 3 Session 15 Endocrine system disorders 2 Bioscience Department www.endeavour.edu.au Session Learning Outcomes At the end of the session, you should be able to:

More information

LYMPHOMA Joginder Singh, MD Medical Oncologist, Mercy Cancer Center

LYMPHOMA Joginder Singh, MD Medical Oncologist, Mercy Cancer Center LYMPHOMA Joginder Singh, MD Medical Oncologist, Mercy Cancer Center Lymphoma is cancer of the lymphatic system. The lymphatic system is made up of organs all over the body that make up and store cells

More information

Pathology #07. Hussein Al-Sa di. Dr. Sohaib Al-Khatib. Mature B-Cell Neoplasm. 0 P a g e

Pathology #07. Hussein Al-Sa di. Dr. Sohaib Al-Khatib. Mature B-Cell Neoplasm. 0 P a g e Pathology #07 Mature B-Cell Neoplasm Hussein Al-Sa di Dr. Sohaib Al-Khatib 0 P a g e Thursday 18/2/2016 Our lecture today (with the next 2 lectures) will be about lymphoid tumors This is a little bit long

More information

155.2 Malignant neoplasm of liver not specified as primary or secondary. C22.9 Malignant neoplasm of liver, not specified as primary or secondary

155.2 Malignant neoplasm of liver not specified as primary or secondary. C22.9 Malignant neoplasm of liver, not specified as primary or secondary ICD-9 TO ICD-10 Reference ICD-9 150.9 Malignant neoplasm of esophagus unspecified site C15.9 Malignant neoplasm of esophagus, unspecified 151.9 Malignant neoplasm of stomach unspecified site C16.9 Malignant

More information

Overview of Aplastic Anemia. Overview of Aplastic Anemia. Epidemiology of aplastic anemia. Normal hematopoiesis 10/6/2017

Overview of Aplastic Anemia. Overview of Aplastic Anemia. Epidemiology of aplastic anemia. Normal hematopoiesis 10/6/2017 Overview of Aplastic Anemia Overview of Aplastic Anemia Peter Westervelt, MD, PhD Professor of Medicine Chief, BMT/Leukemia Section Washington University School of Medicine Epidemiology Normal hematopoiesis

More information

Appendix 6: Indications for adult allogeneic bone marrow transplant in New Zealand

Appendix 6: Indications for adult allogeneic bone marrow transplant in New Zealand Appendix 6: Indications for adult allogeneic bone marrow transplant in New Zealand This list provides indications for the majority of adult BMTs that are performed in New Zealand. A small number of BMTs

More information

Low grade High grade , immune suppression chronic persistent inflammation viruses B-symptoms

Low grade High grade , immune suppression chronic persistent inflammation viruses B-symptoms We've one category for lymphoid neoplasm which is the lymphoma in contrast to that of myeloid which has three categories; acute myeloid leukemias, myeloproliferative & myelodysplastic disorders. Lymphoma

More information

Acute Myeloid Leukemia: A Patient s Perspective

Acute Myeloid Leukemia: A Patient s Perspective Acute Myeloid Leukemia: A Patient s Perspective Patrick A Hagen, MD, MPH Cardinal Bernardin Cancer Center Loyola University Medical Center Maywood, IL Overview 1. What is AML? 2. Who gets AML? Epidemiology

More information

The patient had a mild splenomegaly but no obvious lymph node enlargement. The consensus phenotype obtained from part one of the exercise was:

The patient had a mild splenomegaly but no obvious lymph node enlargement. The consensus phenotype obtained from part one of the exercise was: Case History An 86 year old male was admitted to hospital with chest infection. Haematological examination subsequently revealed the following: Hb- 11.0 g/dl; WBC- 67.1 x 10^9/l; PLT- 99 x10^9/l; RBC-

More information

NON HODGKINS LYMPHOMA: INDOLENT Updated June 2015 by Dr. Manna (PGY-5 Medical Oncology Resident, University of Calgary)

NON HODGKINS LYMPHOMA: INDOLENT Updated June 2015 by Dr. Manna (PGY-5 Medical Oncology Resident, University of Calgary) NON HODGKINS LYMPHOMA: INDOLENT Updated June 2015 by Dr. Manna (PGY-5 Medical Oncology Resident, University of Calgary) Reviewed by Dr. Michelle Geddes (Staff Hematologist, University of Calgary) and Dr.

More information

MYELODYSPLASTIC SYNDROMES: A diagnosis often missed

MYELODYSPLASTIC SYNDROMES: A diagnosis often missed MYELODYSPLASTIC SYNDROMES: A diagnosis often missed D R. EMMA W YPKEMA C O N S U LTA N T H A E M AT O L O G I S T L A N C E T L A B O R AT O R I E S THE MYELODYSPLASTIC SYNDROMES DEFINITION The Myelodysplastic

More information

Table 8.1. Epidemiology of Leukemia in the United States (2010) Annual Deaths. Mean Age. Percentage of All Leukemias (%) (Number of New Cases)

Table 8.1. Epidemiology of Leukemia in the United States (2010) Annual Deaths. Mean Age. Percentage of All Leukemias (%) (Number of New Cases) Table 8.1. Epidemiology of Leukemia in the United States (2010) Type of Leukemia Annual Incidence (Number of New Cases) Percentage of All Leukemias (%) Annual Deaths Mean Age Acute lymphocytic 5,330 12

More information

Lymphoma/CLL 101: Know your Subtype. Dr. David Macdonald Hematologist, The Ottawa Hospital

Lymphoma/CLL 101: Know your Subtype. Dr. David Macdonald Hematologist, The Ottawa Hospital Lymphoma/CLL 101: Know your Subtype Dr. David Macdonald Hematologist, The Ottawa Hospital Function of the Lymph System Lymph Node Lymphocytes B-cells develop in the bone marrow and influence the immune

More information

Assessment and management of patients with hematologic disorder أ.م.د.وداد كامل محمد فرع تمريض البالغين

Assessment and management of patients with hematologic disorder أ.م.د.وداد كامل محمد فرع تمريض البالغين Assessment and management of patients with hematologic disorder أ.م.د.وداد كامل محمد فرع تمريض البالغين Assessment and management of patients with hematologic disorder The hematologic system consists of

More information

Lymphatic system component

Lymphatic system component Introduction Lymphatic system component Statistics Overview Lymphoma Non Hodgkin s Lymphoma Non- Hodgkin's is a type of cancer that originates in the lymphatic system. It is estimated to be the sixth most

More information

Stem cell transplantation. Dr Mohammed Karodia NHLS & UP

Stem cell transplantation. Dr Mohammed Karodia NHLS & UP Stem cell transplantation Dr Mohammed Karodia NHLS & UP The use of haemopoeitic stem cells from a donor harvested from peripheral blood or bone marrow, to repopulate recipient bone marrow. Allogeneic From

More information

Flow Cytometry. Bone Marrow Aspirate and Biopsy. Leukemia and Myelodysplastic Syndromes

Flow Cytometry. Bone Marrow Aspirate and Biopsy. Leukemia and Myelodysplastic Syndromes Diagnostic Evaluation of Blood Disorders Leukemia and Myelodysplastic Syndromes Elise Frans, MN, RN, CWON Oncology CNS University of Washington Medical Center delterzo@uw.edu 1 History & Physical Labs:

More information

Pediatrics. Aplastic Anemia in Children Prognosis and Survival Rate. Definition of Aplastic Anemia. See online here

Pediatrics. Aplastic Anemia in Children Prognosis and Survival Rate. Definition of Aplastic Anemia. See online here Pediatrics Aplastic Anemia in Children Prognosis and Survival Rate See online here Aplastic anemia is a rare disease affecting 1 2 people per one million of the population. The hallmark of the disease

More information

Hematopathology Lab. Third year medical students

Hematopathology Lab. Third year medical students Hematopathology Lab Third year medical students Objectives Identify the lesion Know the specific name of the lesion Know associated disease Know relevant pathologic background Spherocytes: appear small,

More information

Adult Acute leukemia. Matthew Seftel. August

Adult Acute leukemia. Matthew Seftel. August Adult Acute leukemia Matthew Seftel August 21 2007 mseftel@cancercare.mb.ca Principles 3 cases Diagnosis and classification of acute leukemia (AL) Therapy Emergencies Remission induction BMT Complications

More information

Clinical Aspect and Application of Laboratory Test in Herpes Virus Infection. Masoud Mardani M.D,FIDSA

Clinical Aspect and Application of Laboratory Test in Herpes Virus Infection. Masoud Mardani M.D,FIDSA Clinical Aspect and Application of Laboratory Test in Herpes Virus Infection Masoud Mardani M.D,FIDSA Shahidhid Bh BeheshtiMdi Medical lui Universityit Cytomegalovirus (CMV), Epstein Barr Virus(EBV), Herpes

More information

Prepared by: Dr.Mansour Al-Yazji

Prepared by: Dr.Mansour Al-Yazji C L L CLL Prepared by: Abd El-Hakeem Abd El-Rahman Abu Naser Ahmed Khamis Abu Warda Ahmed Mohammed Abu Ghaben Bassel Ziad Abu Warda Nedal Mostafa El-Nahhal Dr.Mansour Al-Yazji LEUKEMIA Leukemia is a form

More information

Rory McCulloch. Specialty Trainee Haematology Royal Devon & Exeter Hospital

Rory McCulloch. Specialty Trainee Haematology Royal Devon & Exeter Hospital Rory McCulloch Specialty Trainee Haematology Royal Devon & Exeter Hospital Anaemia 1 Haematological disorders Anaemia 2 Non-haematological disorders Substrates: Iron, folate, vitamin B12 Red cell mass

More information

CLL & SLL: Current Management & Treatment. Dr. Isabelle Bence-Bruckler

CLL & SLL: Current Management & Treatment. Dr. Isabelle Bence-Bruckler CLL & SLL: Current Management & Treatment Dr. Isabelle Bence-Bruckler Chronic Lymphocytic Leukemia Prolonged clinical course Chronic A particular type of white blood cell B lymphocyte Lymphocytic Cancer

More information

Flow Cytometry. Leukemia and Myelodysplastic Syndromes. Bone Marrow Aspirate and Biopsy

Flow Cytometry. Leukemia and Myelodysplastic Syndromes. Bone Marrow Aspirate and Biopsy Diagnostic Evaluation of Blood Disorders Leukemia and Myelodysplastic Syndromes Lenise Taylor, MN, RN, AOCNS, BMTCN BMT/Immunotherapy CNS Seattle Cancer Care Alliance/UWMC ltaylor@seattlecca.org History

More information

Early diagnosis saves lives #SpotLeukaemia

Early diagnosis saves lives #SpotLeukaemia Early diagnosis saves lives #SpotLeukaemia Leukaemia... is a blood cancer affects people of all ages Leukaemia symptoms are hard to spot, as they are similar to the symptoms of common, unrelated conditions.

More information

Leukocytosis - Some Learning Points

Leukocytosis - Some Learning Points Leukocytosis - Some Learning Points Koh Liang Piu Department of Hematology-Oncology National University Cancer Institute National University Health System Objectives of this talk: 1. To provide some useful

More information

Hematology Unit Lab 2 Review Material

Hematology Unit Lab 2 Review Material Objectives Hematology Unit Lab 2 Review Material - 2018 Laboratory Instructors: 1. Assist students during lab session Students: 1. Review the introductory material 2. Study the case histories provided

More information

GP Referral Guidelines. for. South Wales Cancer Network. Document Control Sheet. Specialty/Project Haematological Site Specific Group

GP Referral Guidelines. for. South Wales Cancer Network. Document Control Sheet. Specialty/Project Haematological Site Specific Group GP Referral Guidelines for South Wales Cancer Network Document Control Sheet Organisation South Wales Cancer Network Specialty/Project Haematological Site Specific Group Document Title GP Referral Guidelines

More information

CLL: disease specific biology and current treatment. Dr. Nathalie Johnson

CLL: disease specific biology and current treatment. Dr. Nathalie Johnson CLL: disease specific biology and current treatment Dr. Nathalie Johnson Disclosures Consultant and Advisory boards Roche, Abbvie, Gilead, Jansson, Lundbeck,Merck Research funding Roche, Abbvie, Lundbeck

More information

Anemia (3).ms4.25.Oct.15 Hemolytic Anemia. Abdallah Abbadi

Anemia (3).ms4.25.Oct.15 Hemolytic Anemia. Abdallah Abbadi Anemia (3).ms4.25.Oct.15 Hemolytic Anemia Abdallah Abbadi Case 3 24 yr old female presented with anemia syndrome and jaundice. She was found to have splenomegaly. Hb 8, wbc 12k, Plt 212k, retics 12%, LDH

More information

Mr Matthew Eby. Dr Humphrey Pullon

Mr Matthew Eby. Dr Humphrey Pullon Dr Humphrey Pullon Haematologist Hamilton Mr Matthew Eby Senior Support Services Coordinator Leukaemia & Blood Cancer Foundation New Zealand Hamilton 16:30-17:25 WS #64: Managing Haemopoetic Disease in

More information

Diseases Of The Blood

Diseases Of The Blood Diseases Of The Blood DR. Associate Professor Of Pathology Faculty Of Medicine Ain Shams University Red Blood Cells and Anemia RBC=4-6 million/mm 2 Hb=12-18 g/dl Oxygen Carrying Molecule Hemoglobin Tetramer:

More information

Understanding your diagnosis. Dr Graham Collins Consultant Haemtologist Oxford University Hospitals

Understanding your diagnosis. Dr Graham Collins Consultant Haemtologist Oxford University Hospitals Understanding your diagnosis Dr Graham Collins Consultant Haemtologist Oxford University Hospitals Common questions I get asked What is lymphoma? What subtype do I have and what does that mean? What are

More information

YEREVAN STATE MEDICAL UNIVERSITY DEPARTMENT OF HEMATOLOGY COURSE DESCRIPTION HEMATOLOGY

YEREVAN STATE MEDICAL UNIVERSITY DEPARTMENT OF HEMATOLOGY COURSE DESCRIPTION HEMATOLOGY 1. Module/unit Code II. 1.2. 2. Module/unit Title Hematology 3. Subject Field Internal Diseases Group 4. Faculty/Department General Medicine, Department of Hematology 5. Programme(s) to which the Doctor

More information

7.342 Chronic infection and inflammation: What are the consequences on your health? Instructors Eva Frickel and Sara Gredmark

7.342 Chronic infection and inflammation: What are the consequences on your health? Instructors Eva Frickel and Sara Gredmark 7.342 Chronic infection and inflammation: What are the consequences on your health? Instructors Eva Frickel and Sara Gredmark How to read a scientific paper Organization of a paper - Title - Authors and

More information

HEMATOLOGIC MALIGNANCIES BIOLOGY

HEMATOLOGIC MALIGNANCIES BIOLOGY HEMATOLOGIC MALIGNANCIES BIOLOGY Failure of terminal differentiation Failure of differentiated cells to undergo apoptosis Failure to control growth Neoplastic stem cell FAILURE OF TERMINAL DIFFERENTIATION

More information